Akèy › Adenokarsinòm folikilè
Etid klinik pou Adenokarsinòm folikilè ap rekrite nan Etazini
5 etid pou Adenokarsinòm folikilè ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Studies on Tumors of the Thyroid
Ap rekriteEtid obsèvasyon
6 Months – 98 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT00001160Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT07545837XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT06959641Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT06440850Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Dec 12, 2024 · NCT05668962Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.